MATERIALS AND METHODS

Antibody Preparation and Administration
Hybridoma LI7FI 2 has been previously described. 
RESULTS
Effect ofAntibody Dose on Cell Clearance
The number of treatments, total dose, and duration of therapy with anti-Leu-I are shown for each patient in Table  I 
J.G. (C). and D.H. (D). Doses and
Characterization of Anti-Mouse Ig Antibody Response
We determined the specificity of the antibodies (Fig. 4) . Therefore, some of the anti-mouse Ig antibodies were directed against variable-region antigenic determinants on the antiLeu-I molecule. The proportion of anti-mouse Ig that was antiidiotypic was less than 4% in patient C.I. and less than 6% in patient J.G. (Table  3) . only.
For 
Attempt to Prevent Host Anti-Mouse Ig Response
We tried to prevent the development of anti-mouse of reactivity against the anti-Leu-l antibody. This absorbed sera was still able to block binding ofanti-Leu-l to its target antigen (Fig. 4) 
